Atara Biotherapeutics, Inc. (ATRA)
9.48
+1.02
(+12.06%)
USD |
NASDAQ |
Oct 02, 16:00
9.60
+0.12
(+1.27%)
After-Hours: 20:00
Atara Biotherapeutics Market Cap : 89.52M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 89.52M |
| October 01, 2026 | 79.89M |
| September 30, 2026 | 80.27M |
| September 29, 2026 | 76.02M |
| September 28, 2026 | 79.04M |
| September 25, 2026 | 83.19M |
| September 24, 2026 | 80.64M |
| September 23, 2026 | 80.83M |
| September 22, 2026 | 84.33M |
| September 21, 2026 | 88.58M |
| September 18, 2026 | 91.50M |
| September 17, 2026 | 91.69M |
| September 16, 2026 | 95.47M |
| September 15, 2026 | 89.14M |
| September 14, 2026 | 87.35M |
| September 11, 2026 | 88.58M |
| September 10, 2026 | 93.39M |
| September 09, 2026 | 93.58M |
| September 08, 2026 | 96.60M |
| September 04, 2026 | 92.16M |
| September 03, 2026 | 89.99M |
| September 02, 2026 | 89.14M |
| September 01, 2026 | 85.18M |
| August 31, 2026 | 84.04M |
| August 28, 2026 | 86.88M |
| Date | Value |
|---|---|
| August 27, 2026 | 87.35M |
| August 26, 2026 | 88.58M |
| August 25, 2026 | 92.92M |
| August 24, 2026 | 89.33M |
| August 21, 2026 | 91.60M |
| August 20, 2026 | 88.58M |
| August 19, 2026 | 90.65M |
| August 18, 2026 | 82.34M |
| August 17, 2026 | 78.94M |
| August 14, 2026 | 76.39M |
| August 13, 2026 | 80.36M |
| August 12, 2026 | 87.11M |
| August 11, 2026 | 84.42M |
| August 10, 2026 | 81.30M |
| August 07, 2026 | 71.93M |
| August 06, 2026 | 70.22M |
| August 05, 2026 | 72.69M |
| August 04, 2026 | 74.65M |
| August 03, 2026 | 72.78M |
| July 31, 2026 | 71.33M |
| July 30, 2026 | 69.54M |
| July 29, 2026 | 68.61M |
| July 28, 2026 | 66.48M |
| July 27, 2026 | 65.63M |
| July 24, 2026 | 67.24M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
| Vericel Corp. | 2.055B |
| Biogen, Inc. | 32.48B |
Market Cap Related Metrics
| PS Ratio | 19.13 |
| PEG Ratio | -0.0296 |
| Price | 9.48 |
| Earnings Yield | -14.75% |
| PEGY Ratio | -0.0296 |